Carfilzomib (Kyprolis▼): risk of reactivation of hepatitis B virus

2019-11-21T14:57:06+00:00

Establish hepatitis B status before initiating carfilzomib and in patients with unknown hepatitis B virus serology who are already being treated with carfilzomib.